Bicycle Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Bicycle Therapeutics has a total shareholder equity of $370.9M and total debt of $30.7M, which brings its debt-to-equity ratio to 8.3%. Its total assets and total liabilities are $595.3M and $224.4M respectively.
Key information
8.3%
Debt to equity ratio
US$30.70m
Debt
Interest coverage ratio | n/a |
Cash | US$526.42m |
Equity | US$370.93m |
Total liabilities | US$224.41m |
Total assets | US$595.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 50BA's short term assets ($561.9M) exceed its short term liabilities ($69.5M).
Long Term Liabilities: 50BA's short term assets ($561.9M) exceed its long term liabilities ($154.9M).
Debt to Equity History and Analysis
Debt Level: 50BA has more cash than its total debt.
Reducing Debt: 50BA's debt to equity ratio has increased from 0% to 8.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 50BA has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 50BA has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 30.5% each year.